VistaGen Therapeutics Receives Notice of Allowance for US Patent for Treatment of Depression with PH10 - Investing News Network

Submitted by Anonymous (not verified) on Wed, 02/13/2019 - 16:38

VistaGen Therapeutics Receives Notice of Allowance for US Patent for Treatment of Depression with PH10  Investing News NetworkVistaGen Therapeutics (NASDAQ:VTGN) has announced that the US Patent and Trademark Office (USPTO) has provided a notice of allowance for a patent to ...